ADRB2 rs1042726: Understanding Your Genetic Variant
The rs1042726 variant is a genetic polymorphism located within the ADRB2 gene, which encodes the beta-2 adrenergic receptor. Research has investigated its potential role in modulating receptor function, lipolysis, and individual responses to endurance training.
What each genotype means
Typical beta-2 receptor responsiveness
You carry two copies of the C allele (frequently annotated in functional studies as coding for Gln27). Research shows that receptors with this genotype undergo normal agonist-induced downregulation, which is associated with standard metabolic lipolysis and average baseline aerobic training responsiveness. If you are taking beta-agonist medications, you should discuss any questions regarding dosing or treatment response directly with your prescribing clinician or pharmacist.
Carried by approximately 30% to 40% of individuals in European and East Asian cohorts, but varies across global populations.
Intermediate endurance training responsiveness
You carry one copy of the C allele and one copy of the G allele (encoding the Gln27Glu substitution). Having this heterozygous genotype is associated with intermediate levels of beta-2 adrenergic receptor downregulation, lipolysis rates, and aerobic conditioning adaptations compared to the homozygotes. Consult your healthcare provider or pharmacist before making any changes if you use bronchodilator or cardiovascular medications that target beta-2 receptors.
Carried by roughly 40% to 50% of people across most global populations, representing the most common genotype.
Altered receptor downregulation profile
You carry two copies of the G allele (commonly referenced as Glu27Glu in the literature), which has been linked to resistance against receptor downregulation upon persistent stimulation. Some studies associate this genotype with higher fat mobilization, distinct body-composition dynamics, and enhanced cardiorespiratory adaptations to endurance training, although published evidence across diverse populations remains limited and mixed. Anyone using beta-adrenergic medications should review their therapy and response with their doctor or pharmacist.
Present in about 15% to 25% of individuals in European and South Asian ancestries, and observed at lower frequencies in East Asian cohorts.
What is the rs1042726 Variant?
The rs1042726 variant is a single nucleotide polymorphism (SNP) found within the ADRB2 gene. In genomics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is located in the region of the genome that provides instructions for the beta-2 adrenergic receptor. Because this receptor is involved in the body's response to catecholamines like epinephrine, researchers have long been interested in whether variations in this gene might influence physiological processes. It is important to note that while this variant is cataloged in genetic databases, it is just one of many variations within the ADRB2 gene. Geneticists study these markers to understand how subtle differences in our DNA sequence might contribute to the wide range of human biological diversity, particularly in how our bodies manage energy and respond to physical stress.
The Role of the ADRB2 Gene
The ADRB2 gene encodes the beta-2 adrenergic receptor, a protein that sits on the surface of cells and acts as a sensor for chemical signals. When molecules like adrenaline bind to this receptor, they trigger a cascade of events inside the cell, such as the breakdown of fats (lipolysis) and the relaxation of smooth muscles in the airways. Because of these functions, the ADRB2 gene is a primary focus in studies related to respiratory health, such as asthma, and metabolic health, including body composition. The receptor is part of the G protein-coupled receptor superfamily, which is essential for many physiological processes. Variations in the gene sequence can potentially alter the structure or expression levels of these receptors, which is why scientists investigate whether certain genotypes might be associated with different metabolic or exercise-related outcomes in various populations.
Research Associations and Evidence
Scientific research into rs1042726 and other ADRB2 variants has explored their potential influence on traits like body mass index (BMI), fat mass, and responsiveness to endurance training. Some studies have suggested that certain ADRB2 genotypes may correlate with how effectively individuals lose body fat or improve their aerobic capacity during structured exercise programs. However, the evidence for these associations is generally considered limited or mixed. Many studies have been conducted in specific, small cohorts, and results often vary significantly between different ancestral groups. For instance, an association observed in one population may not be replicated in another. Consequently, while these findings provide interesting insights into human biology, they are not currently used to predict individual athletic performance or to provide personalized medical advice. The field continues to evolve as larger, more diverse genome-wide association studies are conducted to clarify these complex relationships.
Population Frequency
The rs1042726 variant is relatively common, with a minor allele frequency typically reported between 0.35 and 0.45 across diverse global cohorts. This means that the variant is widely distributed, and many individuals carry at least one copy of the minor allele.
Interpreting Your Genetic Information
It is important to understand that genetic variants like rs1042726 are not deterministic; they do not 'cause' a specific body type or athletic ability. Human traits are complex and result from the interplay of thousands of genetic variants, environmental factors, lifestyle choices, and nutrition. If you have received information about your genotype for this variant, it should be viewed as a small piece of a much larger puzzle. You cannot use this information to diagnose health conditions or to create a definitive exercise or diet plan. If you are interested in how your genetics might relate to your health or fitness, the best approach is to consult with a qualified healthcare professional, such as a physician or a registered dietitian. They can help you interpret information in the context of your overall health history and provide evidence-based guidance tailored to your specific needs.
How common is this variant?
The rs1042726 variant is common, with a minor allele frequency of approximately 0.35 to 0.45 across diverse populations.
Frequently asked questions
Can I use this SNP to predict my athletic potential?
No. While some research has explored associations between ADRB2 variants and exercise response, the evidence is limited and inconsistent. Athletic performance is influenced by many genes and environmental factors, and this SNP cannot reliably predict individual outcomes.
Does this variant mean I have a higher risk of obesity?
No. Genetic variants in the ADRB2 gene are not diagnostic for obesity. Body weight is a complex trait influenced by diet, physical activity, and many different genetic and environmental factors.
Should I change my exercise routine based on my ADRB2 genotype?
You should not change your exercise routine based on a single genetic variant. Always consult with a certified trainer or healthcare provider to develop an exercise program that is safe and appropriate for your personal health goals.
Is this variant related to asthma medication response?
Some ADRB2 variants are studied in the context of asthma pharmacogenetics. However, you should never alter your medication dosage or treatment plan based on genetic information without speaking to your doctor or pharmacist.
Sources & further reading
Educational information only, last refreshed 10/18/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1042726?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ADRB2
Variant in the beta-2 adrenergic receptor linked to metabolic regulation, exercise-induced lipolysis, and endurance performance.
Synonymous polymorphism in the beta-2 adrenergic receptor (Gln27Glu) modulating receptor down-regulation.
The Gln27Glu variant in the beta-2 adrenergic receptor is associated with metabolic and vascular responses to exercise.
Modulates beta-2 adrenergic receptor expression and cardiovascular reactivity.
This variant in the beta-2 adrenergic receptor gene is associated with differential responses to beta-agonist therapy in asthma patients.
Functional variant in the beta-2 adrenergic receptor linked to metabolic rate and cardiovascular reactivity.